Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology

NCT02207179 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

LumaMed

Collaborators